Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. The company was founded in 2004 and is based...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.
Target Price
The average target price of 301122.SZ is 21 and suggests 31% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to
Buy
Sell